{"id":10071,"date":"2026-03-23T08:22:10","date_gmt":"2026-03-23T13:22:10","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=10071"},"modified":"2026-03-23T08:24:28","modified_gmt":"2026-03-23T13:24:28","slug":"nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u7db2\u819c\u75be\u60a3\u306b\u304a\u3051\u308b\u6a5f\u80fd\u7684\u8996\u899a\u8a55\u4fa1\u306b\u7126\u70b9\u3092\u5f53\u3066\u305f\u65b0\u305f\u306a\u7814\u7a76\u8ad6\u6587\u306e\u767a\u8868\u3092\u767a\u8868"},"content":{"rendered":"
\n\t\t\t\t\t\t
\r\n\t\t\t\t\t\t\t\t
\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t
\r\n\r\n\t\t\t\t\r\n\t\t\t\t
\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u30c0\u30e9\u30b9<\/span>,\u00a02026\u5e743\u670823\u65e5<\/span>\u00a0\u2014\u00a0\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e<\/a>, \u7db2\u819c\u5909\u6027\u306b\u3088\u308b\u5149\u53d7\u5bb9\u4f53\u55aa\u5931\u304a\u3088\u3073\u8996\u899a\u969c\u5bb3\u306e\u60a3\u8005\u5411\u3051\u306b\u3001\u75be\u60a3\u3092\u554f\u308f\u306a\u3044\u65b0\u898f\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u304a\u3088\u3073\u5546\u696d\u5316\u306b\u53d6\u308a\u7d44\u3080\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b \u306f\u672c\u65e5\u3001\u30b7\u30e5\u30d7\u30ea\u30f3\u30ac\u30fc\u30fb\u30cd\u30a4\u30c1\u30e3\u30fc\u8a8c\u306b\u6700\u65b0\u306e\u67fb\u8aad\u6e08\u307f\u89b3\u5bdf\u7814\u7a76\u8ad6\u6587\u304c\u63b2\u8f09\u3055\u308c\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002,\u00a0\u773c\u79d1\u5b66\u30c9\u30ad\u30e5\u30e1\u30f3\u30bf<\/i>, \u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u60a3\u8005\u306b\u304a\u3051\u308b\u3001\u73fe\u5b9f\u4e16\u754c\u3067\u610f\u5473\u306e\u3042\u308b\u8996\u529b\u6539\u5584\u3092\u6e2c\u5b9a\u3059\u308b\u65b9\u6cd5\u306b\u3064\u3044\u3066\u306e\u3001\u3053\u306e\u5206\u91ce\u306e\u7406\u89e3\u3092\u6df1\u3081\u308b\u3002.<\/p>\n

\u3053\u306e\u7814\u7a76\u306f\u3001\u687f\u4f53\u7d30\u80de\u3068\u9310\u4f53\u7d30\u80de\u306e\u6a5f\u80fd\u55aa\u5931\u306b\u3088\u308b\u8996\u529b\u4f4e\u4e0b\u306b\u82e6\u3057\u3080\u60a3\u8005\u306b\u5bfe\u3059\u308b\u691c\u67fb\u306e\u5fc5\u8981\u6027\u3092\u5f37\u8abf\u3057\u3001\u6a5f\u80fd\u6539\u5584\u3068\u60a3\u8005\u306e\u7d4c\u9a13\u3092\u6b63\u78ba\u306b\u6349\u3048\u3001\u6a19\u6e96\u7684\u306a\u7db2\u819c\u691c\u67fb\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u3067\u4f7f\u7528\u3067\u304d\u308b\u30c4\u30fc\u30eb\u3092\u91cd\u70b9\u7684\u306b\u53d6\u308a\u4e0a\u3052\u3066\u3044\u308b\u3002.<\/p>\n

\u201c\u300c\u6700\u826f\u77ef\u6b63\u8996\u529b\uff08BCVA\uff09\u306f\u9577\u3089\u304f\u773c\u79d1\u306b\u304a\u3051\u308b\u30b4\u30fc\u30eb\u30c9\u30b9\u30bf\u30f3\u30c0\u30fc\u30c9\u3068\u3055\u308c\u3066\u304d\u307e\u3057\u305f\u304c\u3001\u91cd\u5ea6\u306e\u8996\u529b\u4f4e\u4e0b\u3092\u62b1\u3048\u308b\u60a3\u8005\u3055\u3093\u304c\u65e5\u5e38\u751f\u6d3b\u3092\u3069\u306e\u3088\u3046\u306b\u9001\u3063\u3066\u3044\u308b\u304b\u3092\u8a55\u4fa1\u3059\u308b\u65b0\u305f\u306a\u65b9\u6cd5\u306b\u3088\u3063\u3066\u3001\u305d\u308c\u3092\u88dc\u5b8c\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u300d\u3068\u3001\u7b46\u982d\u8457\u8005\u3067\u3042\u308aNanoscope Therapeutics\u306e\u6700\u9ad8\u79d1\u5b66\u8cac\u4efb\u8005\u3067\u3042\u308bSamarendra Mohanty\u535a\u58eb\u306f\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u67fb\u8aad\u6e08\u307f\u306e\u79c1\u305f\u3061\u306e\u7814\u7a76\u7d50\u679c\u304c\u3001\u81e8\u5e8a\u533b\u3084\u6cbb\u7642\u533b\u304c\u3053\u308c\u3089\u306e\u691c\u67fb\u3092\u7528\u3044\u3066\u60a3\u8005\u3055\u3093\u306e\u6a5f\u80fd\u7684\u8996\u529b\u3092\u8a55\u4fa1\u3059\u308b\u969b\u306b\u81ea\u4fe1\u3092\u6301\u3066\u308b\u3088\u3046\u5f79\u7acb\u3064\u3053\u3068\u3092\u8a87\u308a\u306b\u601d\u3044\u307e\u3059\u3002\u300d\u201d<\/p>\n

\u3053\u306e\u51fa\u7248\u7269\u3067\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u306b\u3088\u308b\u91cd\u5ea6\u306e\u8996\u529b\u4f4e\u4e0b\u60a3\u800525\u540d\u3068\u6b63\u5e38\u8996\u529b\u60a3\u800510\u540d\u3092\u542b\u308035\u540d\u3092\u5bfe\u8c61\u3068\u3057\u305f\u524d\u5411\u304d\u89b3\u5bdf\u7814\u7a76\u306e\u7d50\u679c\u304c\u7d39\u4ecb\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u7814\u7a76\u306f\u3001\u91cd\u5ea6\u306e\u8996\u899a\u969c\u5bb3\u3092\u6301\u3064\u500b\u4eba\u306e\u8996\u899a\u80fd\u529b\u306e\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u30d9\u30fc\u30b9\u306e\u8a55\u4fa1\u3068\u3057\u3066\u3001\u30de\u30eb\u30c1\u8f1d\u5ea6\u5f62\u72b6\u8b58\u5225\u30c6\u30b9\u30c8\uff08MLSDT\uff09\u306e\u4fe1\u983c\u6027\u3068\u59a5\u5f53\u6027\u3092\u652f\u6301\u3059\u308b\u8a3c\u62e0\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u3067BCVA\u3092\u8a55\u4fa1\u3059\u308b\u3053\u3068\u306b\u52a0\u3048\u3066\u3001Nanoscope\u793e\u306e\u4e3b\u8981\u6cbb\u7642\u85acMCO-010\u306eRESTORE\u7b2c2b\/3\u76f8\u81e8\u5e8a\u8a66\u9a13\u3067\u306f\u3001\u526f\u6b21\u8a55\u4fa1\u9805\u76ee\u3067MLSDT\u3092\u4f7f\u7528\u3057\u3066\u60a3\u8005\u306e\u6a5f\u80fd\u7684\u8996\u899a\u3092\u8a55\u4fa1\u3057\u307e\u3057\u305f\u300252\u9031\u76ee\u306b\u306f\u3001MCO-010\u6295\u4e0e\u60a3\u8005\u306e\u5927\u591a\u6570\u304cMLSDT\u30672\u3064\u4ee5\u4e0a\u306e\u8f1d\u5ea6\u30ec\u30d9\u30eb\u306e\u6539\u5584\u3092\u793a\u3057\u3001\u3053\u308c\u306f\u81e8\u5e8a\u7684\u306b\u610f\u7fa9\u306e\u3042\u308b\u6539\u5584\u3067\u3059\u3002MCO-010\u306f\u3001\u30e9\u30f3\u30c0\u30e0\u5316\u30d7\u30e9\u30bb\u30dc\u5bfe\u7167\u767b\u9332\u8a66\u9a13\u306b\u304a\u3044\u3066\u3001\u91cd\u5ea6\u306e\u8996\u529b\u4f4e\u4e0b\u3092\u4f34\u3046RP\u60a3\u8005\u306e\u8996\u899a\u306b\u81e8\u5e8a\u7684\u306b\u610f\u7fa9\u304c\u3042\u308a\u7d71\u8a08\u7684\u306b\u6709\u610f\u306a\u6539\u5584\u3092\u793a\u3057\u305f\u6700\u521d\u306e\u6cbb\u7642\u6cd5\u3067\u3059\u3002.<\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306e\u6700\u9ad8\u533b\u7642\u8cac\u4efb\u8005\u3067\u3042\u308b\u30b5\u30df\u30e5\u30a8\u30eb\u30fb\u30d0\u30ed\u30f3\u533b\u5e2b\u306f\u3001\u300c\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306f\u753b\u671f\u7684\u306a\u5149\u907a\u4f1d\u5b66\u7642\u6cd5\u306e\u958b\u767a\u3092\u901a\u3058\u3066\u696d\u754c\u3092\u30ea\u30fc\u30c9\u3057\u7d9a\u3051\u3066\u3044\u307e\u3059\u304c\u3001\u4eca\u56de\u306e\u89b3\u5bdf\u7814\u7a76\u306f\u3001\u6cbb\u7642\u306e\u6210\u529f\u3092\u3069\u306e\u3088\u3046\u306b\u6e2c\u5b9a\u3059\u308b\u304b\u306b\u3064\u3044\u3066\u3001\u7db2\u819c\u75be\u60a3\u30b3\u30df\u30e5\u30cb\u30c6\u30a3\u3068\u9023\u643a\u3057\u3066\u3044\u304f\u3068\u3044\u3046\u5f53\u793e\u306e\u59ff\u52e2\u3092\u793a\u3059\u3082\u306e\u3067\u3059\u300d\u3068\u4ed8\u3051\u52a0\u3048\u307e\u3057\u305f\u3002\u201c<\/p>\n

\u7814\u7a76\u7d50\u679c\u306fSpringer Nature\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8\u3067\u516c\u958b\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u00a0\u3053\u3053<\/a>.<\/p>\n

MCO\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u3064\u3044\u3066
<\/b>MCO\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\uff08SD\uff09\u3001\u5730\u56f3\u72b6\u840e\u7e2e\u75c7\uff08GA\uff09\u306a\u3069\u306e\u5149\u53d7\u5bb9\u4f53\u5909\u6027\u75c7\u60a3\u8005\u306e\u8996\u529b\u56de\u5fa9\u3092\u76ee\u7684\u3068\u3057\u305f\u3001\u75be\u60a3\u3092\u554f\u308f\u306a\u3044\u5358\u56de\u6295\u4e0e\u306e\u785d\u5b50\u4f53\u5185\u6cbb\u7642\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002MCO\u306f\u3001\u9ad8\u5bc6\u5ea6\u306e\u53cc\u6975\u7db2\u819c\u7d30\u80de\u3092\u6d3b\u6027\u5316\u3057\u3066\u5149\u611f\u53d7\u6027\u3092\u6301\u305f\u305b\u308b\u3053\u3068\u3067\u3001\u5149\u53d7\u5bb9\u4f53\u6b7b\u5f8c\u306b\u6b8b\u5b58\u3059\u308b\u8996\u899a\u56de\u8def\u3092\u6d3b\u7528\u3057\u307e\u3059\u3002MCO\u6cbb\u7642\u306f\u3001\u907a\u4f1d\u5b50\u691c\u67fb\u3001\u4fb5\u8972\u7684\u306a\u624b\u8853\u3001\u307e\u305f\u306f\u7e70\u308a\u8fd4\u3057\u6295\u4e0e\u3092\u5fc5\u8981\u3068\u3057\u306a\u3044\u305f\u3081\u3001\u65e2\u5b58\u306e\u7db2\u819c\u8a3a\u7642\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u5185\u3067\u5e45\u5e83\u3044\u60a3\u8005\u306b\u9069\u7528\u53ef\u80fd\u3067\u3059\u3002.<\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306b\u3064\u3044\u3066
<\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u308a\u5931\u660e\u3057\u305f\u6570\u767e\u4e07\u4eba\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u3001\u75be\u60a3\u3092\u554f\u308f\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\uff08NCT04945772<\/a>\uff09\u3001FDA\u3078\u306eBLA\u7533\u8acb\u306f\u7d99\u7d9a\u7684\u306b\u884c\u308f\u308c\u3066\u3044\u307e\u3059\u3002\u627f\u8a8d\u3055\u308c\u308c\u3070\u3001MCO-010\u306f\u907a\u4f1d\u5b50\u691c\u67fb\u3092\u5fc5\u8981\u3068\u305b\u305a\u3001\u8a3a\u7642\u6240\u30671\u56de\u6ce8\u5c04\u3059\u308b\u3060\u3051\u3067\u6295\u4e0e\u3067\u304d\u308b\u305f\u3081\u3001RP\u60a3\u8005\u306e\u6a19\u6e96\u6cbb\u7642\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u540c\u793e\u306f\u307e\u305f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\uff08SD\uff09\uff08NCT05417126<\/a>\uff09\u3092\u958b\u59cb\u3057\u3001\u00a0\u30d5\u30a7\u30fc\u30ba3\u767b\u9332\u8a66\u9a13<\/a>\u00a02026\u5e74\u306b\u958b\u59cb\u4e88\u5b9a\u3067\u3059\u3002MCO-010\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u3068\u30b9\u30bf\u30d5\u30a3\u30f3\u30fb\u30c0\u30a4\u30a2\u30e2\u30f3\u30c9\u75c7\uff08SD\uff09\u306e\u4e21\u65b9\u3067FDA\u306e\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u304a\u3088\u3073\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u304a\u308a\u3001SD\u306b\u3064\u3044\u3066\u306fRMAT\u6307\u5b9a\u3082\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u975e\u75c7\u5019\u6027\u304a\u3088\u3073\u75c7\u5019\u6027\u306e\u687f\u4f53\u30fb\u9310\u4f53\u512a\u4f4d\u6027\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u3001\u9ec4\u6591\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u3092\u5bfe\u8c61\u3068\u3059\u308bEMA\u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3082\u53d7\u3051\u3066\u3044\u307e\u3059\u3002MCO-010\u306f\u3001\u65e5\u672c\u3067\u306f\u539a\u751f\u52b4\u50cd\u7701\u304b\u3089\u5148\u99c6\u533b\u85ac\u54c1\u304a\u3088\u3073\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u306e\u6307\u5b9a\u3082\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u5730\u7406\u7684\u840e\u7e2e\u75c7\uff08GA\uff09\u306b\u304a\u3051\u308bMCO\u306e\u7b2c2\u76f8\u30d7\u30ed\u30b0\u30e9\u30e0\u30822026\u5e74\u306b\u958b\u59cb\u4e88\u5b9a\u3067\u3059\u3002IND\u7533\u8acb\u6e96\u5099\u4e2d\u306e\u305d\u306e\u4ed6\u306e\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u306f\u3001\u30ec\u30fc\u30d0\u30fc\u5148\u5929\u6027\u9ed2\u5185\u969c\uff08LCA\uff09\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>\n

\u63a5\u89e6\uff1a
<\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e
(817) 857-1186
PR@nanostherapeutics.co<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

DALLAS,\u00a0March 23, 2026\u00a0\u2014\u00a0Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to retinal degeneration, today announced the publication of its latest peer-reviewed observational study in a Springer Nature journal,\u00a0Documenta Ophthalmologica, advancing the field\u2019s understanding of how to measure meaningful vision improvements in patients with severe vision loss in the real world. The study underscores a critical need for testing in patients suffering from loss of vision due to loss of rod and cone functions, highlighting tools that accurately capture functional improvements and patient experience, and can be used in standard retina workflows. \u201cWhile best-corrected visual acuity […]<\/p>\n","protected":false},"author":1,"featured_media":10072,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-10071","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Therapeutics Announces Publication of New Study Highlighting Functional Vision Assessment in Retinal Disease - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Announces Publication of New Study Highlighting Functional Vision Assessment in Retinal Disease - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-23T13:22:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-23T13:24:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Wilson PJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Wilson PJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/23\\\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/23\\\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\\\/\"},\"author\":{\"name\":\"Wilson PJ\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/2fa4c7d9fcf90c2c01f1341935baf02d\"},\"headline\":\"Nanoscope Therapeutics Announces Publication of New Study Highlighting Functional Vision Assessment in Retinal Disease\",\"datePublished\":\"2026-03-23T13:22:10+00:00\",\"dateModified\":\"2026-03-23T13:24:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/23\\\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\\\/\"},\"wordCount\":650,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/23\\\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_MLSD-Publication_REV2.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/23\\\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/23\\\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\\\/\",\"name\":\"Nanoscope Therapeutics Announces Publication of New Study Highlighting Functional Vision Assessment in Retinal Disease - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/23\\\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/23\\\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_MLSD-Publication_REV2.jpg\",\"datePublished\":\"2026-03-23T13:22:10+00:00\",\"dateModified\":\"2026-03-23T13:24:28+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/23\\\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/23\\\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/23\\\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_MLSD-Publication_REV2.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_MLSD-Publication_REV2.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/23\\\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Announces Publication of New Study Highlighting Functional Vision Assessment in Retinal Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/2fa4c7d9fcf90c2c01f1341935baf02d\",\"name\":\"Wilson PJ\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u7db2\u819c\u75be\u60a3\u306b\u304a\u3051\u308b\u6a5f\u80fd\u7684\u8996\u899a\u8a55\u4fa1\u306b\u7126\u70b9\u3092\u5f53\u3066\u305f\u65b0\u305f\u306a\u7814\u7a76\u8ad6\u6587\u306e\u767a\u8868\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics Announces Publication of New Study Highlighting Functional Vision Assessment in Retinal Disease - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2026-03-23T13:22:10+00:00","article_modified_time":"2026-03-23T13:24:28+00:00","og_image":[{"width":1200,"height":242,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","type":"image\/jpeg"}],"author":"Wilson PJ","twitter_card":"summary_large_image","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Wilson PJ","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/"},"author":{"name":"Wilson PJ","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/2fa4c7d9fcf90c2c01f1341935baf02d"},"headline":"Nanoscope Therapeutics Announces Publication of New Study Highlighting Functional Vision Assessment in Retinal Disease","datePublished":"2026-03-23T13:22:10+00:00","dateModified":"2026-03-23T13:24:28+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/"},"wordCount":650,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_MLSD-Publication_REV2.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/","url":"https:\/\/nanostherapeutics.com\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u7db2\u819c\u75be\u60a3\u306b\u304a\u3051\u308b\u6a5f\u80fd\u7684\u8996\u899a\u8a55\u4fa1\u306b\u7126\u70b9\u3092\u5f53\u3066\u305f\u65b0\u305f\u306a\u7814\u7a76\u8ad6\u6587\u306e\u767a\u8868\u3092\u767a\u8868 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_MLSD-Publication_REV2.jpg","datePublished":"2026-03-23T13:22:10+00:00","dateModified":"2026-03-23T13:24:28+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_MLSD-Publication_REV2.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_MLSD-Publication_REV2.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2026\/03\/23\/nanoscope-therapeutics-announces-publication-of-new-study-highlighting-functional-vision-assessment-in-retinal-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Announces Publication of New Study Highlighting Functional Vision Assessment in Retinal Disease"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/2fa4c7d9fcf90c2c01f1341935baf02d","name":"\u30a6\u30a3\u30eb\u30bd\u30f3 PJ"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/10071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=10071"}],"version-history":[{"count":4,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/10071\/revisions"}],"predecessor-version":[{"id":10076,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/10071\/revisions\/10076"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/10072"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=10071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=10071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=10071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}